Cargando…

Role of TGF-β in breast cancer bone metastases

Breast cancer is the most prevalent cancer among females worldwide leading to approximately 350,000 deaths each year. It has long been known that cancers preferentially metastasize to particular organs, and bone metastases occur in ~70% of patients with advanced breast cancer. Breast cancer bone met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiechi, Antonella, Waning, David L., Stayrook, Keith R., Buijs, Jeroen T., Guise, Theresa A., Mohammad, Khalid S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928102/ https://www.ncbi.nlm.nih.gov/pubmed/24558636 http://dx.doi.org/10.4236/abb.2013.410A4003

Ejemplares similares

The Role of TGF-β in Bone Metastases
por: Trivedi, Trupti, et al.
Publicado: (2021)

Excess TGF-β mediates muscle weakness associated with bone metastases in mice
por: Waning, David L., et al.
Publicado: (2015)

Hypoxia and TGF-β Drive Breast Cancer Bone Metastases through Parallel Signaling Pathways in Tumor Cells and the Bone Microenvironment
por: Dunn, Lauren K., et al.
Publicado: (2009)

Spontaneous bone metastases in a preclinical orthotopic model of invasive lobular carcinoma; the effect of pharmacological targeting TGFβ receptor I kinase
por: Buijs, Jeroen T, et al.
Publicado: (2015)

Halofuginone inhibits TGF-β/BMP signaling and in combination with zoledronic acid enhances inhibition of breast cancer bone metastasis
por: Juárez, Patricia, et al.
Publicado: (2017)

Osteolytic Breast Cancer Causes Skeletal Muscle Weakness in an Immunocompetent Syngeneic Mouse Model
por: Regan, Jenna N., et al.
Publicado: (2017)

Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo
por: Wright, Laura E., et al.
Publicado: (2016)

Chemotherapy-induced loss of bone and muscle mass in a mouse model of breast cancer bone metastases and cachexia
por: Hain, Brian A., et al.
Publicado: (2019)

A Role for TGFβ Signaling in Preclinical Osteolytic Estrogen Receptor-Positive Breast Cancer Bone Metastases Progression
por: Cheng, Julia N., et al.
Publicado: (2021)

Doxorubicin-Mediated Bone Loss in Breast Cancer Bone Metastases Is Driven by an Interplay between Oxidative Stress and Induction of TGFβ
por: Rana, Tapasi, et al.
Publicado: (2013)

Correction: Doxorubicin-Mediated Bone Loss in Breast Cancer Bone Metastases Is Driven by an Interplay between Oxidative Stress and Induction of TGFβ
por: Rana, Tapasi, et al.
Publicado: (2013)

FRI685 Denosumab Withdrawal Is Associated With Hypercalcemia In Adults With Osteoporosis And Bone Metastases
por: Patil, Madhuri D, et al.
Publicado: (2023)

Pharmacologic Inhibition of the TGF-β Type I Receptor Kinase Has Anabolic and Anti-Catabolic Effects on Bone
por: Mohammad, Khalid S., et al.
Publicado: (2009)

The role of bisphosphonates in breast cancer: Actions of bisphosphonates in animal models of breast cancer
por: Padalecki, Susan S, et al.
Publicado: (2002)

Genetically Engineered Hematopoietic Stem Cells Deliver TGF‐β Inhibitor to Enhance Bone Metastases Immunotherapy
por: Wang, Beilei, et al.
Publicado: (2022)

Decreased Autocrine EGFR Signaling in Metastatic Breast Cancer Cells Inhibits Tumor Growth in Bone and Mammary Fat Pad
por: Nickerson, Nicole K., et al.
Publicado: (2012)

TGF-β Signaling in Breast Cancer Cell Invasion and Bone Metastasis
por: Drabsch, Yvette, et al.
Publicado: (2011)

A modified hTERT Promoter-directed Oncolytic Adenovirus Replication with Concurrent Inhibition of TGFβ Signaling for Breast Cancer Therapy
por: Hu, Zebin, et al.
Publicado: (2009)

Bone Microenvironment‐Suppressed T Cells Increase Osteoclast Formation and Osteolytic Bone Metastases in Mice
por: Arellano, Danna L., et al.
Publicado: (2022)

The bone–muscle connection in breast cancer: implications and therapeutic strategies to preserve musculoskeletal health
por: Ballinger, Tarah J., et al.
Publicado: (2022)

Role of bone-anabolic agents in the treatment of breast cancer bone metastases
por: Suvannasankha, Attaya, et al.
Publicado: (2014)

Analysis and variability of TGFβ measurements in cancer patients with skeletal metastases
por: O’Brien, Peter J, et al.
Publicado: (2008)

Tumor-expressed adrenomedullin accelerates breast cancer bone metastasis
por: Siclari, Valerie A, et al.
Publicado: (2014)

Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast Cancer
por: D’Oronzo, Stella, et al.
Publicado: (2020)

Differential Notch and TGFβ Signaling in Primary Colorectal Tumors and Their Corresponding Metastases
por: Veenendaal, Liesbeth M., et al.
Publicado: (2008)

Interaction of tumor cells and astrocytes promotes breast cancer brain metastases through TGF-β2/ANGPTL4 axes
por: Gong, Xianghui, et al.
Publicado: (2019)

Role of TGF-β 1 and TGF-β Type II Receptor in Gastric Cancer
por: Park, Dong Il, et al.
Publicado: (2002)

Epigenetic Reprogramming of TGF-β Signaling in Breast Cancer
por: Suriyamurthy, Sudha, et al.
Publicado: (2019)

TGFβ-facilitated optic fissure fusion and the role of bone morphogenetic protein antagonism
por: Knickmeyer, Max D., et al.
Publicado: (2018)

TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression
por: Lamora, Audrey, et al.
Publicado: (2016)

BMP and TGFβ use and release in bone regeneration
por: BAL, Zeynep, et al.
Publicado: (2020)

TGF-β Activity of a Demineralized Bone Matrix
por: Panahipour, Layla, et al.
Publicado: (2021)

The Role of TGF-β Receptors in Fibrosis
por: Nakerakanti, Sashidhar, et al.
Publicado: (2012)

Interleukin 11 (IL-11): Role(s) in Breast Cancer Bone Metastases
por: Maroni, Paola, et al.
Publicado: (2021)

Role of TGF-β receptor III localization in polarity and breast cancer progression
por: Meyer, Alison E., et al.
Publicado: (2014)

Role of TG2 and TGF-β(1) in the pathogenesis of human breast cancer
por: Gao, Hai-Cheng, et al.
Publicado: (2020)

Bone abnormalities in latent TGF-β binding protein (Ltbp)-3–null mice indicate a role for Ltbp-3 in modulating TGF-β bioavailability
por: Dabovic, Branka, et al.
Publicado: (2002)

Sex Differences and Bone Metastases of Breast, Lung, and Prostate Cancers: Do Bone Homing Cancers Favor Feminized Bone Marrow?
por: Farach-Carson, Mary C., et al.
Publicado: (2017)

Myofibroblastic stromal reaction and lymph node status in invasive breast carcinoma: possible role of the TGF-β1/TGF-βR1 pathway
por: Catteau, Xavier, et al.
Publicado: (2014)

TGF-β Type I Receptor Signaling in Melanoma Liver Metastases Increases Metastatic Outgrowth
por: Marvin, Dieuwke L., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i6icdabo4bhiqbt72trif3uioh